Combined effect of obesity and metabolic profile on glomerular dysfunction in hypertensive subjects
暂无分享,去创建一个
[1] T. Jenssen,et al. Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population. , 2018, Kidney international.
[2] D. Zanetta,et al. Aging and decreased glomerular filtration rate: An elderly population-based study , 2017, PloS one.
[3] J. Caramori,et al. Recognition of visceral obesity beyond body fat: assessment of cardiovascular risk in chronic kidney disease using anthropometry , 2017, Nutrire.
[4] Bruce W Bailey,et al. Expanded Normal Weight Obesity and Insulin Resistance in US Adults of the National Health and Nutrition Examination Survey , 2017, Journal of diabetes research.
[5] C. Lee,et al. Effect of synergistic interaction between abnormal adiposity-related metabolism and prediabetes on microalbuminuria in the general population , 2017, PloS one.
[6] Jianghua Chen,et al. Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis , 2016, Oncotarget.
[7] P. Valensi,et al. Are Obese Individuals with no Feature of Metabolic Syndrome but Increased Waist Circumference Really Healthy? A Cross Sectional Study. , 2016, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[8] N. Nakamura,et al. Metabolically healthy obesity and risk of incident CKD. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[9] K. Sharma,et al. Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis , 2015, Current opinion in nephrology and hypertension.
[10] Hongmei Li,et al. Interaction of Obesity and Central Obesity on Elevated Urinary Albumin-to-Creatinine Ratio , 2014, PloS one.
[11] W. Gulliver,et al. Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[12] L. Weinrauch,et al. Pathophysiology of Obesity-Related Renal Dysfunction Contributes to Diabetic Nephropathy , 2012, Current Diabetes Reports.
[13] E. Randell,et al. The Prevalence of Metabolically Healthy Obese Subjects Defined by BMI and Dual‐Energy X‐Ray Absorptiometry , 2011, Obesity.
[14] Tyler J. VanderWeele,et al. Estimating measures of interaction on an additive scale for preventive exposures , 2011, European Journal of Epidemiology.
[15] F Paccaud,et al. Normal weight obesity: relationship with lipids, glycaemic status, liver enzymes and inflammation. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[16] G. Parati,et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. , 2010, European heart journal.
[17] B. Kasiske,et al. Kidney Disease: Improving Global Outcomes , 2009, Nature Reviews Nephrology.
[18] R. Mak,et al. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[19] R. Lipsy. Introduction , 2003, Journal of managed care pharmacy : JMCP.
[20] A. Ahlbom,et al. How to evaluate interaction between causes: a review of practices in cardiovascular epidemiology , 1996, Journal of internal medicine.
[21] Christine Maric-Bilkan. Obesity and diabetic kidney disease. , 2013, The Medical clinics of North America.